Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Jun 15;24(1):738.
doi: 10.1186/s12885-024-12503-3.

The association between XPD rs13181 and rs1799793 polymorphism and oral cancer risk: evidence from a meta-analysis

Wenli Zeng  1 , Wanting Xu  1 , Wu Long  2
Affiliations
Meta-Analysis

The association between XPD rs13181 and rs1799793 polymorphism and oral cancer risk: evidence from a meta-analysis

Wenli Zeng et al. BMC Cancer. .

Abstract

Objective: Single nucleotide polymorphisms (SNPs) are common in genes and can lead to dysregulation of gene expression in tissues, which can affect carcinogenesis. Many studies reporting the association between xeroderma pigmentosum group D (XPD) polymorphisms of rs13181 and rs1799793 with oral cancer risk, but with conflicting and inconclusive results.

Methods: We performed a comprehensive and systematic search through the PubMed, Elsevier, Web of science, and Embase databases, twelve studies were included in the meta-analysis to determine whether XPD rs13181 and rs1799793 polymorphism contributed to the risk of oral cancer.

Results: The pooled date indicated a significant association between the rs13181 polymorphism and oral cancer risk for the allele comparison model (odds ratio, OR = 1.60, 95% confidence intervals, CI = 1.09-2.35, P = 0.02), the dominant model (OR = 1.74, 95% CI = 1.08-2.82, P = 0.02), and the heterozygote model (OR = 1.59, 95% CI = 1.02-2.49, P = 0.04). For the XPD rs1799793 polymorphism, it is not associated with the incidence of oral cancer under any model. Subgroup analyses based on ethnicity indicated that the rs13181 polymorphism increased the risk of oral cancer among Asians according to the allele comparison model (OR = 1.97, 95% CI = 1.10-3.51, P = 0.02), the dominant model (OR = 2.35, 95% CI = 1.25-4.44, P = 0.008), the heterozygote model (OR = 2.05, 95% CI = 1.15-3.66, P = 0.01), and the homozygous model (OR = 2.47, 95% CI = 1.06-5.76, P = 0.04).

Conclusion: Our meta-analysis suggests a positive correlation between XPD rs13181polymorphism and the development of oral cancer among Asians, but a negative correlation among Caucasians populations.

Keywords: Meta-analysis; Oral cancer; SNP; XPD; rs13181; rs1799793.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow diagram of the details of the study
Fig. 2
Fig. 2
Forest plot for the meta-analysis of the association between XPD rs13181 polymorphism and oral cancer risk (under allele comparison model)
Fig. 3
Fig. 3
Forest plot for the meta-analysis of the association between XPD rs13181 polymorphism and oral cancer risk (under dominant comparison model)
Fig. 4
Fig. 4
Forest plot for the meta-analysis of the association between XPD rs13181 polymorphism and oral cancer risk (under heterozygote comparison model)
Fig. 5
Fig. 5
Forest plot for the meta-analysis of the association between XPD rs13181 polymorphism and oral cancer risk (under recessive comparison model)
Fig. 6
Fig. 6
Forest plot for the meta-analysis of the association between XPD rs13181 polymorphism and oral cancer risk (under homozygous comparison model)
Fig. 7
Fig. 7
Results for the meta-analysis of the association between XPD rs1799793 polymorphism and oral cancer risk
Fig. 8
Fig. 8
One-way sensitivity analysis of the pooled ORs and 95% CI, omitting each dataset in the meta-analysis. (under allele comparison model)
Fig. 9
Fig. 9
Funnel plot for the meta-analysis of the association between XPD rs13181 polymorphism and oral cancer risk. (under allele comparison model)
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: etiology and risk factors: a review. J Cancer Res Ther. 2016;12(2):458–63. doi: 10.4103/0973-1482.186696. - DOI - PubMed
    1. Hsieh MJ, Lo YS, Ho HY, Lin CC, Chuang YC, Chen MK. The Interaction between CLSPN Gene polymorphisms and Alcohol Consumption contributes to oral Cancer progression. Int J Mol Sci 2024, 25(2). - PMC - PubMed
    1. Yeh JC, Chen YT, Chou YE, Su SC, Chang LC, Chen YL, Lin CW, Yang SF. Interactive effects of CDKN2B-AS1 gene polymorphism and habitual risk factors on oral cancer. J Cell Mol Med. 2023;27(21):3395–403. doi: 10.1111/jcmm.17966. - DOI - PMC - PubMed
    1. Tiwari S, Pandey R, Kumar V, Das S, Gupta V, Vishwakarma S, Nema R, Sindhuja T, Hashmi S, Kumar A. Association of single nucleotide polymorphism miRNA-146a (rs2910164) with increased predisposition to oral squamous cell carcinoma in central India population. Cancer Biomark A. 2023;38(2):203–14. doi: 10.3233/CBM-230064. - DOI - PubMed

Substances